anagrelide

This medicine is used to reduce an increased number of blood platelets (thrombocytes) in people with essential thrombocythemia. This helps to reduce the risk of circulatory and blood clotting problems.

Form: tablets

ATC: L01XX35

Manufacturer: QPharma AB

This medicine is used to reduce an increased number of platelets (thrombocytes) in patients with essential thrombocythemia. This helps to reduce the risk of circulatory and blood clotting problems.

Form: tablets

ATC: L01XX35

Manufacturer: QPharma AB

This medicine is used to treat essential thrombocythemia. It helps reduce the production of platelets by the bone marrow, bringing their number down to a more normal level.

Form: capsules, hard

ATC: L01XX35

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This medicine is used to treat essential thrombocythemia. It helps to reduce the production of platelets by the bone marrow, which reduces their number in the blood to a normal level.

Form: capsules, hard

ATC: L01XX35

Manufacturer: Synthon B.V., Synthon Hispania S.L.

It is used in the treatment of essential thrombocythemia. This medicine inhibits the development of platelets, which helps to reduce their number to a more normal level.

Form: capsules, hard

ATC: L01XX35

Manufacturer: Galenicum Health, S.L.U. Glenmark Pharmaceuticals s.r.o. NOUCOR HEALTH, S.A.

This medicine is used to reduce an increased number of blood platelets (thrombocytes) in people suffering from essential thrombocythemia. This helps to reduce the risk of circulatory and blood clotting problems.

Form: tablets

ATC: L01XX35

Manufacturer: QPharma AB

The medicine is used to treat patients with essential thrombocythemia. It helps to reduce the number of platelets produced by the bone marrow, which leads to restoring their count to a more normal level.

Form: capsules, hard

ATC: L01XX35

Manufacturer: Galenicum Health, S.L.U. Lek Pharmaceuticals d.d. NOUCOR HEALTH, S.A. SAG MANUFACTURING, S.L.U. Salutas Pharma GmbH

This medicine is used to treat patients with essential thrombocythemia. It helps to reduce the production of platelets by the bone marrow, bringing their number down to a more normal level.

Form: capsules, hard

ATC: L01XX35

Manufacturer: Centrafarm Services B.V.

This medicine is used to treat essential thrombocythemia. It helps to reduce the number of platelets by limiting their production by the bone marrow, which prevents serious circulatory and clotting disorders.

Form: capsules, hard

ATC: L01XX35

Manufacturer: Synthon B.V., Synthon Hispania S.L.

This medicine is used to treat essential thrombocythemia. It helps to reduce the number of platelets by limiting their production by the bone marrow, which prevents serious circulatory and clotting disorders.

Form: capsules, hard

ATC: L01XX35

Manufacturer: Synthon B.V., Synthon Hispania S.L.

The medicine is intended for the treatment of essential thrombocythemia.

Form: capsules, hard

ATC: L01XX35

Manufacturer: AOP Orphan Pharmaceuticals GmbH